BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
ERBB2
,
glucose metabolic process
,
Pseudomonas infection
,
Embryo
,
DNA fingerprint
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
SH2D1A
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Thymus gland
T Lymphocyte (regulatory) of peripheral blood
T Lymphocyte (CD8+) of peripheral blood
T Lymphocyte (CD4+) of peripheral blood
Natural killer cell of peripheral blood
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Loading...
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Loading...
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Loading...
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Overexpression of SH2D1A promotes cancer progression and is associated with immune cell infiltration…
Exon skipping caused by a complex structural variation in SH2D1A resulted in X-linked lymphoprolifer…
Case Report: Meningoencephalitis With Thrombotic Occlusive Vasculopathy in a Young EBV-Naïve Boy Is …
Asymptomatic incidental neuroblastoma in a patient with SH2D1A deficiency.
A novel pathogenic SH2D1A mutation for X-linked lymphoproliferative syndrome type 1.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Children and Adult Hemophagocytic Syndrome (HLHa)
A Prospective Clinical Study of Ruxolitinib and Etoposide Combined With DDGP Regimen (RUE-DDGP) in I…
Therapeutic Use of Tadekinig Alfa in NLRC4 Mutation and XIAP Deficiency
Use Of A Response-Adapted Ruxolitinib-Containing Regimen For The Treatment Of Hemophagocytic Lymphoh…
Reduced Intensity Conditioning for Hemophagocytic Syndromes or Selected Primary Immune Deficiencies …
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ